(Q38090730)

28 August 2017

Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium (English)

1 reference

28 August 2017

0 references

3

Dawn A Marcus

1 reference

28 August 2017

Cheryl D Bernstein

1

1 reference

PubMed ID

23506481

28 August 2017

Kara L Albrecht

series ordinal

2

1 reference

PubMed ID

23506481

28 August 2017

language of work or name

English

0 references

publication date

19 March 2013

1 reference

Expert Opinion on Pharmacotherapy

28 August 2017

1 reference

28 August 2017

14

1 reference

28 August 2017

7

1 reference

28 August 2017

905-916

1 reference

Is there a therapeutic window with some antidepressants for analgesic response?

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Prevalence of fibromyalgia: a survey in five European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Candidate gene studies of fibromyalgia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Pharmacological treatment of fibromyalgia syndrome: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Antidepressant treatment of fibromyalgia. A meta-analysis and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Treatment of fibromyalgia with antidepressants: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

QTc intervals in drug poisoning patients with tricyclic antidepressants and selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

21 January 2018

Antidepressants and pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Venlafaxine Treatment of Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Milnacipran: beyond a role of antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Milnacipran. A review of its use in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Milnacipran: in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Pharmacodynamics of milnacipran in young and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Comorbidity of fibromyalgia and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Fibromyalgia and obesity: the hidden link

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Effect of milnacipran on body weight in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Pregabalin for the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Available therapies and current management of fibromyalgia: focusing on pharmacological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

An internet survey of 2,596 people with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

Patient perspectives on the impact of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.779670

10.1517/14656566.2013.779670

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23506481